Judges Scientific plc (the "Company")
Director dealing
The Company announces that on 28 September 2015 Ralph Cohen, non-executive director, exercised options over 6,100 new ordinary shares of 5p each in the Company ("Ordinary Shares") under the Company's Unapproved Share Option Scheme.
Date of issue |
Number of options |
Exercise price (£) |
23 July 2009 |
1,100 |
0.92 |
9 May 2011 |
5,000 |
4.70 |
Mr Cohen's resulting increased interest in the Company is 64,341 Ordinary Shares representing 1.06 per cent. of the issued Company's ordinary share capital. In addition, he holds remaining options over 1,775 Ordinary Shares under the Company's Share Option Plans.
Following the allotment of these shares, the enlarged issued Ordinary share capital is 6,075,049 Ordinary Shares.
For further information please contact:
Judges Scientific Plc
David Cicurel, CEO
Brad Ormsby, Group FD
Tel: 020 3829 6970
Shore Capital (Nominated Adviser & Broker)
Pascal Keane
Edward Mansfield
Tel: 020 7408 4090
Cardew Group (Financial Public Relations)
Nadja Vetter
Tel: 020 7930 0777 or 07941 340 836